Bis-Iridoid Glycosides and Triterpenoids from Kolkwitzia amabilis and Their Potential as Inhibitors of ACC1 and ACL
- PMID: 39770069
- PMCID: PMC11678491
- DOI: 10.3390/molecules29245980
Bis-Iridoid Glycosides and Triterpenoids from Kolkwitzia amabilis and Their Potential as Inhibitors of ACC1 and ACL
Abstract
A comprehensive phytochemical investigation of the twigs/leaves and flower buds of Kolkwitzia amabilis, a rare deciduous shrub native to China, led to the isolation of 39 structurally diverse compounds. These compounds include 11 iridoid glycosides (1-4 and 7-13), 20 triterpenoids (5, 6, and 14-31), and 8 phenylpropanoids (32-39). Among these, amabiliosides A (1) and B (2) represent previously undescribed bis-iridoid glycosides, while amabiliosides C (3) and D (4) feature a unique bis-iridoid-monoterpenoid indole alkaloid scaffold with a tetrahydro-β-carboline-5-carboxylic acid moiety. Amabiliacids A (5) and B (6) are 24-nor-ursane-type triterpenoids characterized by an uncommon ∆11,13(18) transannular double bond. Their chemical structures and absolute configurations were elucidated through spectroscopic data and electronic circular dichroism analyses. Compound 2 exhibited a moderate inhibitory effect against acetyl CoA carboxylase 1 (ACC1), with an IC50 value of 9.6 μM. Lonicejaposide C (8), 3β-O-trans-caffeoyl-olean-12-en-28-oic acid (29), and (23E)-coumaroylhederagenin (31) showed notable inhibitory effects on ATP-citrate lyase (ACL), with IC50 values of 3.6, 1.6, and 4.7 μM, respectively. Additionally, 3β-acetyl-ursolic acid (17) demonstrated dual inhibitory activity against both ACC1 and ACL, with IC50 values of 10.3 and 2.0 μM, respectively. The interactions of the active compounds with ACC1 and ACL enzymes were examined through molecular docking studies. From a chemotaxonomic perspective, the isolation of bis-iridoid glycosides in this study may aid in clarifying the taxonomic relationship between the genera Kolkwitzia and Lonicera within the Caprifoliaceae family. These findings highlight the importance of conserving plant species with unique and diverse secondary metabolites, which could serve as potential sources of new therapeutic agents for treating ACC1/ACL-associated diseases.
Keywords: ATP-citrate lyase; Kolkwitzia amabilis; acetyl CoA carboxylase 1; bis-iridoid glycosides; triterpenoids.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Structurally diverse glycosides of secoiridoid, bisiridoid, and triterpene-bisiridoid conjugates from the flower buds of two Caprifoliaceae plants and their ATP-citrate lyase inhibitory activities.Bioorg Chem. 2022 Mar;120:105630. doi: 10.1016/j.bioorg.2022.105630. Epub 2022 Jan 19. Bioorg Chem. 2022. PMID: 35091291
-
Fortunefuroic Acid J from Keteleeria Hainanensis and its Dual Inhibitory Effects on ATP-Citrate Lyase and Acetyl-CoA Carboxylase.Chem Biodivers. 2024 Dec;21(12):e202401520. doi: 10.1002/cbdv.202401520. Epub 2024 Oct 26. Chem Biodivers. 2024. PMID: 39221607
-
Structurally Diverse Triterpene-26-oic Acids as Potential Dual ACL and ACC1 Inhibitors from the Vulnerable Conifer Keteleeria fortunei.J Nat Prod. 2023 Jun 23;86(6):1487-1499. doi: 10.1021/acs.jnatprod.3c00181. Epub 2023 Jun 8. J Nat Prod. 2023. PMID: 37291059
-
Phytochemical and biological studies on rare and endangered plants endemic to China. Part XXXVI. Tsugaforrestiacids A-O: Structurally diverse C-18 carboxylated diterpenoids from the twigs and needles of the 'vulnerable' conifer Tsuga forrestii and their inhibitory effects on ATP-citrate lyase.Phytochemistry. 2024 Oct;226:114221. doi: 10.1016/j.phytochem.2024.114221. Epub 2024 Jul 11. Phytochemistry. 2024. PMID: 39002688
-
[Research progress on chemical constituents and pharmacological activities of iridoid glycosides in Lonicera japonica].Zhongguo Zhong Yao Za Zhi. 2021 Jun;46(11):2746-2752. doi: 10.19540/j.cnki.cjcmm.20210108.602. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 34296571 Review. Chinese.
References
-
- Chinese Pharmacopoeia Commission . Pharmacopoeia of the People’s Republic of China Part I. Chinese Medical Science and Technology Press; Beijing, China: 2020.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous